Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods
暂无分享,去创建一个
Jean-Michel Antoine | Francisco Guarner | F. Guarner | H. Hendriks | J. Woodside | B. Koletzko | C. Patterson | M. Richelle | A. Bub | R. Welch | M. Jäkel | S. Theis | Jean-Louis Berta | Achim Bub | O. Hasselwander | J. Antoine | Chris C Patterson | Jayne V Woodside | Berthold V Koletzko | Robert W Welch | Jan de Vries | Oliver Hasselwander | Henk Hendriks | Martin Jäkel | Myriam Richelle | Maria Skarp | Stephan Theis | Stéphane Vidry | Maria Skarp | J. Berta | Jan de Vries | S. Vidry
[1] I. Borecki,et al. Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in 2 white populations. , 2008, The American journal of clinical nutrition.
[2] 王林,et al. CONSORT , 2011 .
[3] F. Branca,et al. Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. , 2008, The American journal of clinical nutrition.
[4] Feng Chen,et al. Novel omics technologies in nutrition research. , 2008, Biotechnology advances.
[5] P. Morgan. International committee of medical journal editors. , 1983, Canadian Medical Association journal.
[6] M. Cabana,et al. Guide to designing, conducting, publishing, and communicating results of clinical studies involving probiotic applications in human participants , 2010, Gut microbes.
[7] M. Palmer. Clinical Trials: A Practical Approach , 1985 .
[8] Catherine M Champagne,et al. The evidence for dietary prevention and treatment of cardiovascular disease. , 2008, Journal of the American Dietetic Association.
[9] Efsa Panel on Dietetic Products. Scientific and technical guidance for the preparation and presentation of an application for authorisation of a health claim (revision 1) , 2011 .
[10] B. Sandström. Quality criteria in human experimental nutrition research. , 1995, European journal of clinical nutrition.
[11] Draft Guidance. Contains Nonbinding Recommendations Guidance for Industry ! Evidence-Based Review System for the Scientific Evaluation of Health Claims , 2007 .
[12] R. Nahin,et al. Guidance from an NIH Workshop on Designing, Implementing, and Reporting Clinical Studies of Soy Interventions1–4 , 2010, The Journal of nutrition.
[13] 廣畑 富雄,et al. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective , 2007 .
[14] Peter Fayers,et al. Randomized Clinical Trials: Design, Practice and Reporting , 2010 .
[15] Ursel Wahrburg,et al. What are the health effects of fat? , 2004, European journal of nutrition.
[16] K. Krleza-Jeric. Clinical Trial Registration: The Differing Views of Industry, the WHO, and the Ottawa Group , 2005, PLoS medicine.
[17] N. Asp,et al. Process for the Assessment of Scientific Support for Claims on Foods (PASSCLAIM): overall introduction , 2003, European journal of nutrition.
[18] D. Moher,et al. Issues related to the conduct of systematic reviews: a focus on the nutrition field. , 2008, The American journal of clinical nutrition.
[19] D. DeMets,et al. Fundamentals of Clinical Trials , 1982 .
[20] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.
[21] C. Cooper,et al. PASSCLAIM – Bone health and osteoporosis , 2003, European journal of nutrition.
[22] World Medical Association (WMA),et al. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.
[23] J. Lupton,et al. Funding food science and nutrition research: financial conflicts and scientific integrity. , 2009, The Journal of nutrition.
[24] J. Abraham. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .
[25] F. Bellisle,et al. PASSCLAIM, Process for the Assessment of Scientific Support for Claims on Foods , 2005 .
[26] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[27] P. Jones,et al. Optimizing clinical trial design for assessing the efficacy of functional foods. , 2010, Nutrition reviews.
[28] S Senn,et al. Analysis of serial measurements in medical research. , 1990, BMJ.
[29] M. Hills,et al. The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.
[30] J. Davis. Clinical Trials: a Methodological Perspective, 2nd edn by S. Piantadosi , 2007 .
[31] A. Zauber,et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .
[32] M Thorogood,et al. Dietary advice for reducing cardiovascular risk. , 2013, The Cochrane database of systematic reviews.
[33] M. Hills,et al. The two-period cross-over clinical trial. 1979. , 2004, British journal of clinical pharmacology.
[34] J. Rafter,et al. PASSCLAIM¶Process for the Assessment of Scientific Support for Claims on Foods , 2003 .
[35] S A Bingham,et al. Limitations of the various methods for collecting dietary intake data. , 1991, Annals of nutrition & metabolism.
[36] J. German,et al. PASSCLAIM – Diet-related cardiovascular disease , 2003, European journal of nutrition.
[37] F. Bellisle,et al. PASSCLAIM: consensus on criteria. , 2005, European journal of nutrition.
[38] H. Hauner,et al. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension , 2007, European journal of nutrition.
[39] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[40] R. Peto,et al. Clinical trial methodology , 1978, Nature.